Do PON1 genetic variants affect my risk for liver fibrosis?

Liver fibrosis is the scarring that happens when the liver is injured over time. This scarring can lead to serious conditions like cirrhosis. Research shows that the body's antioxidant defenses play a key role in preventing this damage. One important enzyme involved in this defense is paraoxonase 1, or PON1. Genetic differences in the PON1 gene can alter how much of this enzyme is made and how active it is. These changes affect a person's susceptibility to metabolic disorders and liver scarring.

What the research says

PON1 is an enzyme found in the liver that helps protect cells from oxidative stress by cleaning up oxidized lipids. When this enzyme does not work well, the liver is more vulnerable to damage from chronic inflammation and metabolic issues. Studies have identified specific genetic markers, such as rs2057681 and rs854572, that determine the level of PON1 activity in the blood. Individuals with certain combinations of these markers may have lower enzyme activity, which increases their risk for conditions like diabetes and liver fibrosis ³.

The link between these genetic variants and liver health is clear because they directly impact the body's ability to handle oxidative stress. Oxidative stress is a state where harmful molecules build up and damage cells. If PON1 activity is low due to genetics, the liver cannot clear these harmful molecules effectively. This leads to a cycle of injury and repair that eventually results in fibrosis. The research highlights that these genetic factors are significant determinants of whether a person develops dysglycemia and liver fibrosis ³.

While other treatments and therapies are being developed to reverse fibrosis, understanding a patient's genetic background helps explain why some people progress to scarring faster than others. Current medical approaches focus on reprogramming immune cells and using metabolic therapies to stop the progression of liver disease. However, the underlying genetic risk remains a critical factor in a patient's overall prognosis and response to treatment ¹⁴.

What to ask your doctor

• Could my genetic variants in the PON1 gene affect my risk for liver fibrosis?
• How does my specific PON1 enzyme activity level relate to my current liver health?
• Are there lifestyle changes that can help protect my liver if I have lower PON1 activity?
• Should I get genetic testing to understand my personal risk for metabolic liver disease?